GH

Quote

Short

News

Articles

Message Board

GH Price Target Alert: $129.00. Issued by Raymond James

February 23, 2026 10:03:56 am

Source: KlickAnalytics

2026-02-23 10:03:56 ET

from Raymond James issued a price target of $129.00 for GH on 2026-02-23 14:41:39.

The adjusted price target was set to $129.00.

At the time of the announcement, GH was trading at $97.4888.

The overall price target consensus is at $127.50 with high price of $175.00, low price of $75.00, and median price is at $130.00.

GH currently trades -13.43% v ...
Full story available on KlickAnalytics.com

Guardant Health Inc.

NASDAQ: GH

GH Trading

1.94% G/L:

$85.48 Last:

1,130,601 Volume:

$84.77 Open:

mwn-link-x Ad 300

GH Latest News

March 13, 2026 08:05:00 am

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

March 10, 2026 08:05:00 am

Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

March 04, 2026 07:00:00 am

Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

March 03, 2026 07:00:00 am

Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

GH Stock Data

Market Cap $13,330,105,573

Float 118,352,583

Insiders Ownership 3.47%

Institutions 191

Short Percent N/A

Industry Medical Diagnostics & Screening

Sector Healthcare

Website https://www.guardanthealth.com

Country US

City Palo Alto

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App